For women of childbearing potential, note that GLP-1 medications for weight management are contraindicated during pregnancy, and some agents should be discontinued at least two months before planned conception
with an annual subscription and includes video consults with a licensed clinician, labs, messaging, access to prescriptions for weight loss medications, and ongoing care
Who we are Our website address is: What personal data we collect and why we collect it Comments When visitors leave comments on the site we collect the data shown in the comments form, and also the visitors IP address and browser user agent string to help spam detection
Clinical Studies 14.1 Overview of Clinical Trials BYDUREON has been studied in adult patients with type 2 diabetes mellitus as monotherapy and in combination with metformin, a sulfonylurea, a thiazolidinedione, a combination of metformin and a sulfonylurea, a combination of metformin and a thiazolidinedione, in combination with a SGLT2 inhibitor on a background of metformin, and in combination with basal insulin [see Clinical Studies (14.2, 14.3)]